Verapamil Hydrochloride Injection, Solution
Product Images NDC 51662-1685

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Verapamil Hydrochloride (NDC 51662-1685). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (51662 1685 Structure)

FDA Label Image

Table (51662 1685 Table 1)

This document gives recommended treatments for acute cardiovascular adverse reactions. It includes suggested medications and interventions for managing symptomatic hypotension, bradycardia, AV block, asystole, and rapid ventricular rate. Supportive treatments like intravenous fluids, positioning, and monitoring are also described. Note that experiences with these treatments are limited due to the low frequency of these adverse reactions.*

FDA Label Image

Label (51662 1685 1 Rfidlabel)

The text provides critical information about a product's identification numbers, a manufacturer's insert note, and distribution details. It also mentions that the product is for prescription only. Additionally, it indicates that the product is distributed by HF Acquisition Co., LLC based in Mukilteo, WA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.